Meeting
2018 Genitourinary Cancers Symposium
P53 as a predictor of clinical outcome in localized prostate cancer.
Authors
Kate Lynette Mahon
Chris O'Brien Lifehouse, Camperdown, Australia
Kate Lynette Mahon , Phillip Stricker , James Kench , Judith Grogan , Warick Delprado , Jenny Turner , Lisa Horvath , David I. Quinn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 57)
DOI
10.1200/JCO.2018.36.6_suppl.57
Abstract #
57
Poster Bd #
C21
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Genomic predictors of biochemical failure following radical prostatectomy.
First Author: Sanjay Aneja
Poster
2023 ASCO Genitourinary Cancers Symposium
Germline APC (I1307K) mutation and clinical outcomes in prostate cancer.
First Author: Minas P. Economides
Poster
2023 ASCO Genitourinary Cancers Symposium
Effect of prostate brachytherapy case volume in the community setting on oncologic outcomes.
First Author: Kevin Chang
Poster
2022 ASCO Annual Meeting
Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic castration-sensitive prostate cancer: A pooled analysis of the STOMP and ORIOLE trials.
First Author: Mathew Pierre Deek